Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
Beckers, Igor ; O'Rourke, Galahad ; De Vos, Dirk Synthesis,2022,54(2):334-340. DOI: 10.1055/s-0037-1610784
More
Abstract: The C-H arylation of indoles holds the promise to shorten synthetic routes in the production of pharmaceuticals. However, late-stage C-H activation reactions often rely on the presence of protecting groups or stoichiometric metal additives. The regiospecific C-H arylation of a highly functionalized azepino[5,3,4-cd]indole scaffold lacking directing groups via Pd(II) and Cu(II) co-catalysis is reported. The direct C-H coupling was demonstrated in the convergent synthesis of rucaparib, an FDA approved anticancer drug.
Keywords: C-H activation ; indole ; arylation ; homogeneous catalysis ; palladium ; copper ; organic synthesis ; pharmaceuticals
Purchased from AmBeed: 283173-50-2 ; 1408282-26-7
CAS No. : | 1408282-26-7 | MDL No. : | MFCD23381312 |
Formula : | C11H9FN2O | Boiling Point : | No data available |
Linear Structure Formula : | - | InChI Key : | XXKDRTXIEZBWPZ-UHFFFAOYSA-N |
M.W : | 204.20 | Pubchem ID : | 71503507 |
Synonyms : |
|
Signal Word: | Warning | Class: | |
Precautionary Statements: | P280 | UN#: | |
Hazard Statements: | H302-H317 | Packing Group: | |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 198474-05-4 ]
3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione
Similarity: 0.84
[ 283173-80-8 ]
2-Bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one
Similarity: 0.83
[ 198474-05-4 ]
3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione
Similarity: 0.84
[ 283173-80-8 ]
2-Bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one
Similarity: 0.83
[ 283173-80-8 ]
2-Bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one
Similarity: 0.83
[ 1151397-80-6 ]
9-Fluoro-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one
Similarity: 0.82
[ 145485-58-1 ]
6-Fluoro-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one
Similarity: 0.82
[ 1143-50-6 ]
5H-Dibenzo[b,e]azepine-6,11-dione
Similarity: 0.73